APO Research

APO RESEARCH · REPORT

Prostaglandin D2 Receptor 2

Selected research

Industry Growth & Trends

Global Prostaglandin D2 Receptor 2 Industry Growth and Trends Forecast to 2032

Market perspective

The global Prostaglandin D2 Receptor 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostaglandin D2 Receptor 2 include Novartis AG, Merck & Co., Inc., Taisho Pharmaceutical Holdings Co., Ltd., Pulmagen Therapeutics LLP, Panmira Pharmaceuticals, LLC., Oxagen Limited, Ligand Pharmaceuticals, Inc., Brickell Biotech, Inc. and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostaglandin D2 Receptor 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostaglandin D2 Receptor 2 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostaglandin D2 Receptor 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostaglandin D2 Receptor 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostaglandin D2 Receptor 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostaglandin D2 Receptor 2 Market by Company

Novartis AG

Merck & Co., Inc.

Taisho Pharmaceutical Holdings Co., Ltd.

Pulmagen Therapeutics LLP

Panmira Pharmaceuticals, LLC.

Oxagen Limited

Ligand Pharmaceuticals, Inc.

Brickell Biotech, Inc.

Allergan Plc

Prostaglandin D2 Receptor 2 Segment by Type

ADC-7405

BBI-5000

MK-1029

OC-2417

Others

Prostaglandin D2 Receptor 2 Segment by Application

Atopic Dermatitis

Chronic Obstructive Pulmonary Disease

Allergic Asthma

Others

Prostaglandin D2 Receptor 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin D2 Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin D2 Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin D2 Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostaglandin D2 Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ADC-7405 Table 2. Major Company of BBI-5000 Table 3. Major Company of MK-1029 Table 4. Major Company of OC-2417 Table 5. Major Company of Others Table 6. Global Prostaglandin D2 Receptor 2 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 8. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type (2021-2026) Table 11. Global Prostaglandin D2 Receptor 2 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Prostaglandin D2 Receptor 2 Sales by Type (2027-2032) & (W Units) Table 13. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Prostaglandin D2 Receptor 2 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type (2027-2032) Table 16. Global Prostaglandin D2 Receptor 2 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 18. North America Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 20. Europe Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 24. Latin America Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (US$ Million) Table 27. Prostaglandin D2 Receptor 2 Industry Trends Table 28. Prostaglandin D2 Receptor 2 Industry Drivers Table 29. Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges Table 30. Prostaglandin D2 Receptor 2 Industry Restraints Table 31. Global Prostaglandin D2 Receptor 2 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Company (2021-2026) Table 33. Global Prostaglandin D2 Receptor 2 Sales by Company (2021-2026) & (W Units) Table 34. Global Prostaglandin D2 Receptor 2 Sales Share by Company (2021-2026) Table 35. Global Prostaglandin D2 Receptor 2 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Prostaglandin D2 Receptor 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Prostaglandin D2 Receptor 2 Major Company Production Sites and Headquarters Table 38. Global Prostaglandin D2 Receptor 2 Company, Product Type & Application Table 39. Global Prostaglandin D2 Receptor 2 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Prostaglandin D2 Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Prostaglandin D2 Receptor 2 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2026) & (W Units) Table 44. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Region (2021-2026) Table 47. Global Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Prostaglandin D2 Receptor 2 Sales by Region (2027-2032) & (W Units) Table 49. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Prostaglandin D2 Receptor 2 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Region (2027-2032) Table 52. Global Prostaglandin D2 Receptor 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Prostaglandin D2 Receptor 2 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 55. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application (2021-2026) Table 58. Global Prostaglandin D2 Receptor 2 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Prostaglandin D2 Receptor 2 Sales by Application (2027-2032) & (W Units) Table 60. Global Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Prostaglandin D2 Receptor 2 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application (2027-2032) Table 63. Global Prostaglandin D2 Receptor 2 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 65. North America Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 67. Europe Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 71. Latin America Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio Table 78. Novartis AG Recent Development Table 79. Merck & Co., Inc. Company Information Table 80. Merck & Co., Inc. Business Overview Table 81. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 83. Merck & Co., Inc. Recent Development Table 84. Taisho Pharmaceutical Holdings Co., Ltd. Company Information Table 85. Taisho Pharmaceutical Holdings Co., Ltd. Business Overview Table 86. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio Table 88. Taisho Pharmaceutical Holdings Co., Ltd. Recent Development Table 89. Pulmagen Therapeutics LLP Company Information Table 90. Pulmagen Therapeutics LLP Business Overview Table 91. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio Table 93. Pulmagen Therapeutics LLP Recent Development Table 94. Panmira Pharmaceuticals, LLC. Company Information Table 95. Panmira Pharmaceuticals, LLC. Business Overview Table 96. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio Table 98. Panmira Pharmaceuticals, LLC. Recent Development Table 99. Oxagen Limited Company Information Table 100. Oxagen Limited Business Overview Table 101. Oxagen Limited Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio Table 103. Oxagen Limited Recent Development Table 104. Ligand Pharmaceuticals, Inc. Company Information Table 105. Ligand Pharmaceuticals, Inc. Business Overview Table 106. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 108. Ligand Pharmaceuticals, Inc. Recent Development Table 109. Brickell Biotech, Inc. Company Information Table 110. Brickell Biotech, Inc. Business Overview Table 111. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 113. Brickell Biotech, Inc. Recent Development Table 114. Allergan Plc Company Information Table 115. Allergan Plc Business Overview Table 116. Allergan Plc Prostaglandin D2 Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio Table 118. Allergan Plc Recent Development Table 119. North America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. North America Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 121. North America Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 122. North America Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032) & (W Units) Table 123. North America Prostaglandin D2 Receptor 2 Sales Market Share Forecast by Country (2027-2032) Table 124. North America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Prostaglandin D2 Receptor 2 Market Share by Country (2021-2026) Table 127. North America Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Prostaglandin D2 Receptor 2 Market Share Forecast by Country (2027-2032) Table 129. Europe Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Europe Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 131. Europe Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 132. Europe Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032) & (W Units) Table 133. Europe Prostaglandin D2 Receptor 2 Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Prostaglandin D2 Receptor 2 Market Share by Country (2021-2026) Table 137. Europe Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Prostaglandin D2 Receptor 2 Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 141. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032) & (W Units) Table 143. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Prostaglandin D2 Receptor 2 Market Share by Country (2021-2026) Table 147. Asia-Pacific Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Prostaglandin D2 Receptor 2 Market Share Forecast by Country (2027-2032) Table 149. Latin America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. Latin America Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 151. Latin America Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 152. Latin America Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032) & (W Units) Table 153. Latin America Prostaglandin D2 Receptor 2 Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Prostaglandin D2 Receptor 2 Market Share by Country (2021-2026) Table 157. Latin America Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Prostaglandin D2 Receptor 2 Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 161. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032) & (W Units) Table 163. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Prostaglandin D2 Receptor 2 Market Share by Country (2021-2026) Table 167. Middle East and Africa Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Prostaglandin D2 Receptor 2 Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Prostaglandin D2 Receptor 2 Distributors List Table 172. Prostaglandin D2 Receptor 2 Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Prostaglandin D2 Receptor 2 Image Figure 2. Global Prostaglandin D2 Receptor 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin D2 Receptor 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin D2 Receptor 2 Sales (2021-2032) & (W Units) Figure 5. ADC-7405 Image Figure 6. Global ADC-7405 Sales YoY Growth (2021-2032) & (W Units) Figure 7. BBI-5000 Image Figure 8. Global BBI-5000 Sales YoY Growth (2021-2032) & (W Units) Figure 9. MK-1029 Image Figure 10. Global MK-1029 Sales YoY Growth (2021-2032) & (W Units) Figure 11. OC-2417 Image Figure 12. Global OC-2417 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Prostaglandin D2 Receptor 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Prostaglandin D2 Receptor 2 Market Share by Type 2025 VS 2032 Figure 17. North America Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type in 2025 Figure 18. North America Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type in 2025 Figure 19. Europe Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Prostaglandin D2 Receptor 2 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Atopic Dermatitis Image Figure 30. Global Atopic Dermatitis Sales YoY Growth (2021-2032) & (W Units) Figure 31. Chronic Obstructive Pulmonary Disease Image Figure 32. Global Chronic Obstructive Pulmonary Disease Sales YoY Growth (2021-2032) & (W Units) Figure 33. Allergic Asthma Image Figure 34. Global Allergic Asthma Sales YoY Growth (2021-2032) & (W Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Prostaglandin D2 Receptor 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Prostaglandin D2 Receptor 2 Market Share by Application 2025 VS 2032 Figure 39. North America Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application in 2025 Figure 40. North America Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application in 2025 Figure 41. Europe Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application in 2025 Figure 42. Europe Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application in 2025 Figure 45. Latin America Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share in Value by Application in 2025 Figure 49. North America Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Prostaglandin D2 Receptor 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Prostaglandin D2 Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Prostaglandin D2 Receptor 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Prostaglandin D2 Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Prostaglandin D2 Receptor 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Prostaglandin D2 Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Prostaglandin D2 Receptor 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Prostaglandin D2 Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Prostaglandin D2 Receptor 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Prostaglandin D2 Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Prostaglandin D2 Receptor 2 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Prostaglandin D2 Receptor 2 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ADC-7405
  • BBI-5000
  • MK-1029
  • OC-2417
  • Others
Applications
  • Atopic Dermatitis
  • Chronic Obstructive Pulmonary Disease
  • Allergic Asthma
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Pulmagen Therapeutics LLP
  • Panmira Pharmaceuticals, LLC.
  • Oxagen Limited
  • Ligand Pharmaceuticals, Inc.
  • Brickell Biotech, Inc.
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostaglandin D2 Receptor 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostaglandin D2 Receptor 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostaglandin D2 Receptor 2 Market by Type
  6. 1.3.1 ADC-7405
  7. 1.3.2 BBI-5000
  8. 1.3.3 MK-1029
  9. 1.3.4 OC-2417
  10. 1.3.5 Others
  11. 1.4 Global Prostaglandin D2 Receptor 2 Market Size by Type
  12. 1.4.1 Global Prostaglandin D2 Receptor 2 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Prostaglandin D2 Receptor 2 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Prostaglandin D2 Receptor 2 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Prostaglandin D2 Receptor 2 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Prostaglandin D2 Receptor 2 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Prostaglandin D2 Receptor 2 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Prostaglandin D2 Receptor 2 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostaglandin D2 Receptor 2 Industry Trends
  2. 2.2 Prostaglandin D2 Receptor 2 Industry Drivers
  3. 2.3 Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin D2 Receptor 2 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostaglandin D2 Receptor 2 Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostaglandin D2 Receptor 2 Sales (2021-2026)
  3. 3.3 Global Top Players by Prostaglandin D2 Receptor 2 Price (2021-2026)
  4. 3.4 Global Prostaglandin D2 Receptor 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostaglandin D2 Receptor 2 Major Company Production Sites & Headquarters
  6. 3.6 Global Prostaglandin D2 Receptor 2 Company, Product Type & Application
  7. 3.7 Global Prostaglandin D2 Receptor 2 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostaglandin D2 Receptor 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostaglandin D2 Receptor 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostaglandin D2 Receptor 2 Tier 1, Tier 2, and Tier 3
4 Prostaglandin D2 Receptor 2 Regional Status and Outlook
  1. 4.1 Global Prostaglandin D2 Receptor 2 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostaglandin D2 Receptor 2 Historic Market Size by Region
  3. 4.2.1 Global Prostaglandin D2 Receptor 2 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostaglandin D2 Receptor 2 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostaglandin D2 Receptor 2 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostaglandin D2 Receptor 2 Forecasted Market Size by Region
  7. 4.3.1 Global Prostaglandin D2 Receptor 2 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostaglandin D2 Receptor 2 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostaglandin D2 Receptor 2 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostaglandin D2 Receptor 2 by Application
  1. 5.1 Prostaglandin D2 Receptor 2 Market by Application
  2. 5.1.1 Atopic Dermatitis
  3. 5.1.2 Chronic Obstructive Pulmonary Disease
  4. 5.1.3 Allergic Asthma
  5. 5.1.4 Others
  6. 5.2 Global Prostaglandin D2 Receptor 2 Market Size by Application
  7. 5.2.1 Global Prostaglandin D2 Receptor 2 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Prostaglandin D2 Receptor 2 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Prostaglandin D2 Receptor 2 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Prostaglandin D2 Receptor 2 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Prostaglandin D2 Receptor 2 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Prostaglandin D2 Receptor 2 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Prostaglandin D2 Receptor 2 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Taisho Pharmaceutical Holdings Co., Ltd.
  14. 6.3.1 Taisho Pharmaceutical Holdings Co., Ltd. Company Information
  15. 6.3.2 Taisho Pharmaceutical Holdings Co., Ltd. Business Overview
  16. 6.3.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio
  18. 6.3.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Developments
  19. 6.4 Pulmagen Therapeutics LLP
  20. 6.4.1 Pulmagen Therapeutics LLP Company Information
  21. 6.4.2 Pulmagen Therapeutics LLP Business Overview
  22. 6.4.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio
  24. 6.4.5 Pulmagen Therapeutics LLP Recent Developments
  25. 6.5 Panmira Pharmaceuticals, LLC.
  26. 6.5.1 Panmira Pharmaceuticals, LLC. Company Information
  27. 6.5.2 Panmira Pharmaceuticals, LLC. Business Overview
  28. 6.5.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio
  30. 6.5.5 Panmira Pharmaceuticals, LLC. Recent Developments
  31. 6.6 Oxagen Limited
  32. 6.6.1 Oxagen Limited Company Information
  33. 6.6.2 Oxagen Limited Business Overview
  34. 6.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio
  36. 6.6.5 Oxagen Limited Recent Developments
  37. 6.7 Ligand Pharmaceuticals, Inc.
  38. 6.7.1 Ligand Pharmaceuticals, Inc. Company Information
  39. 6.7.2 Ligand Pharmaceuticals, Inc. Business Overview
  40. 6.7.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  42. 6.7.5 Ligand Pharmaceuticals, Inc. Recent Developments
  43. 6.8 Brickell Biotech, Inc.
  44. 6.8.1 Brickell Biotech, Inc. Company Information
  45. 6.8.2 Brickell Biotech, Inc. Business Overview
  46. 6.8.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  48. 6.8.5 Brickell Biotech, Inc. Recent Developments
  49. 6.9 Allergan Plc
  50. 6.9.1 Allergan Plc Company Information
  51. 6.9.2 Allergan Plc Business Overview
  52. 6.9.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio
  54. 6.9.5 Allergan Plc Recent Developments
7 North America by Country
  1. 7.1 North America Prostaglandin D2 Receptor 2 Sales by Country
  2. 7.1.1 North America Prostaglandin D2 Receptor 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  4. 7.1.3 North America Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostaglandin D2 Receptor 2 Market Size by Country
  6. 7.2.1 North America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostaglandin D2 Receptor 2 Sales by Country
  2. 8.1.1 Europe Prostaglandin D2 Receptor 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostaglandin D2 Receptor 2 Market Size by Country
  6. 8.2.1 Europe Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Country
  2. 9.1.1 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostaglandin D2 Receptor 2 Market Size by Country
  6. 9.2.1 Asia-Pacific Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostaglandin D2 Receptor 2 Sales by Country
  2. 10.1.1 South America Prostaglandin D2 Receptor 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  4. 10.1.3 South America Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostaglandin D2 Receptor 2 Market Size by Country
  6. 10.2.1 South America Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country
  2. 11.1.1 Middle East and Africa Prostaglandin D2 Receptor 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostaglandin D2 Receptor 2 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country
  6. 11.2.1 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostaglandin D2 Receptor 2 Value Chain Analysis
  2. 12.1.1 Prostaglandin D2 Receptor 2 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostaglandin D2 Receptor 2 Production Mode & Process
  7. 12.2 Prostaglandin D2 Receptor 2 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostaglandin D2 Receptor 2 Distributors
  10. 12.2.3 Prostaglandin D2 Receptor 2 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research